Omkar Speciality Chemicals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
Awaiting price reaction for this filing.
Omkar Speciality Chemicals Limited filed unaudited financial results for Q1 FY26 (Jun 2025), Q2 FY26 (Sep 2025), and Q3 FY26 (Dec 2025). The company's auditor, R.R. Tibrewala & Co., issued a qualified conclusion on all three sets of results. Key concerns include: the company was under Corporate Insolvency Resolution Process (CIRP) during the review period, reported losses in each quarter, and has negative net worth indicating a going concern uncertainty. Financial results for the first three quarters of FY 2024-25 were not prepared, making comparative figures unavailable across all filings. A Resolution Plan was approved by NCLT on 31 July 2025, after the reporting period, which the auditor noted as an emphasis of matter but did not modify the conclusion.
The qualified opinion, ongoing losses, negative net worth, and CIRP status signal significant financial distress despite the Resolution Plan approval. Shareholders should monitor the implementation of the Resolution Plan closely, as the going concern basis depends on its successful execution.